Aimmune
Aimmune is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of food allergies.
Business Model:
Revenue: $14.5M
Employees: 201-500
Industries / Tags:
Detailed Aimmune Information
Aimmune was acquired by
Nestlé Health Science.
The acquisition happend on 2020-08-31.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 8000 Marina Boulevard
City: Brisbane
State: CA
Zip: 94005-1884
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$200M
Raised Total:$540M
Social
Metrics
3,639,681Website Global Rank
3,630Website Monthly Traffic
Twitter Followers
Description
Aimmune is a biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of food allergies.
Contact Phone:
+16506145220
Contact Email:
Aimmune went public on 8/14/2015 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
8/14/2015
Ticker Symbol:
AIMT
IPO Price:
$16/share
Amount Raised:
$160M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
